75704-51-7

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
1-Amino-5,6,7,8-tetrahydroisoquinoline is used as a research compound for the study and synthesis of potential central nervous system drugs. It is being investigated for its potential anti-inflammatory and analgesic properties.
Used in Neurological and Psychiatric Disorders:
1-Amino-5,6,7,8-tetrahydroisoquinoline is used as a therapeutic agent in the development of treatments for neurological and psychiatric disorders. It has shown promise in preclinical studies for its ability to modulate neurotransmitter systems.

Upstream product

• 1532-84-9 isoquinolin-1-ylamine 
• 36556-06-6 5,6,7,8-tetrahydroisoquinoline 
• 121-69-7 N,N-dimethyl-aniline 
• 119-65-3 isoquinoline 

Downstream Products

• 50388-18-6 1-bromo-5,6,7,8-tetrahydro-isoquinoline 
• 26345-15-3 5,6,7,8-tetrahydro-isoquinolin-1-ol 

Relevant academic research and scientific papers

And circular PI3K inhibitors (by machine translation)

The invention belongs to the field of medical technology, in particular to general formula (I) and of the everted shown in the PI3K inhibitor, or a pharmaceutically acceptable salt, ester, stereo isomers, solvates, wherein R 1, R 2, R 3 as defined in the specification. The invention also relates to methods of preparing such compounds, pharmaceutical formulations containing these compounds and pharmaceutical compositions, use of these compounds in the preparation and treatment and/or prevention of proliferative diseases of application of the medicament. (by machine translation)

HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.

Substituted 2-aminopyridines as inhibitors of nitric oxide synthase

Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders. STR1